Quilter Plc’s CytomX Therapeutics CTMX Stock Holding History

Quilter Plc’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30,000	Closed	-$232K	–	367
2021 Q1	$232K	Buy	+30,000	New	+$237K	0.01%	282

Other funds holding CTMX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Quilter Plc's CTMX Position: Q2 2021 in Review

Quilter Plc sold out of CytomX Therapeutics (CTMX) in Q2 2021, closing a stake of 30,000 shares — an estimated $232K sold.

Quilter Plc first reported a position in CTMX in Q1 2021 and held it in 1 quarter. The position peaked at $232K in Q1 2021. 122 funds tracked by Wall St. Rank hold CTMX as of Q2 2021.

Quilter Plc reported no remaining CytomX Therapeutics position as of Q2 2021 after selling out during the quarter.
Quilter Plc sold 30,000 CytomX Therapeutics shares in Q2 2021, an estimated $232K.
Quilter Plc first reported a position in CytomX Therapeutics in Q1 2021 and held it in 1 quarter.
Quilter Plc's CytomX Therapeutics position peaked at $232K in Q1 2021.
122 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2021.

Based on Quilter Plc's 13F filing for Q2 2021, filed 12 Aug 2021.